LuciAda
Original price was: $1,800.00.$1,649.78Current price is: $1,649.78.
LuciAda is an inhibitor of the RAS GTPase family indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least one prior systemic therapy.
In Stock
Description
COMPOSITION:
Each film-coated tablet contains Adagrasib……………………………. 200 mg
INDICATION:
LuciAda is an inhibitor of the RAS GTPase family indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least one prior systemic therapy.
DOSAGE AND USE:
• Recommended dosage: 600 mg orally twice daily.
• Swallow tablets whole with or without food.
STORAGE:
in a dry place and store at 20°C to 25°C.
MANUFACTURED AND MARKETED BY:
LUCIUS PHARMACEUTICALS(LAO) CO., LTD
No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos
WARNING:
Keep medicine out of reach of Children. Do not administer LuciAda during Pregnancy and Lactation.
Reviews
There are no reviews yet.